Persistent deficits in social interaction and communication and interaction as well as a markedly restricted repertoire of activity and interest as well as repetitive patterns of behavior.
Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation on autism is limited due to its multifactorial nature and the complexity of its clinical presentation. Because autism affects a diverse population and encompasses a wide range of symptoms and severity, systematic studies have been challenging. Additionally, the lack of identified genes complicates the understanding of its etiology, making comprehensive clinical characterization ongoing.
The clinical features of autism often present with neurological symptoms such as EEG abnormalities and seizures, occurring in 30-79% of cases. Additionally, many individuals exhibit increased serum serotonin levels, which can also be a notable characteristic. These features highlight the complexity of autism and the variability in its presentation among individuals.
To navigate autism effectively, consider consulting with a developmental pediatrician or a child psychologist who specializes in autism spectrum disorders. These specialists can provide tailored assessments and interventions. Additionally, you may explore resources such as the National Institute of Mental Health (NIMH) website at nimh.nih.gov for research updates and support. While no patient organizations are currently identified, participating in clinical trials may offer access to cutting-edge therapies and contribute to the understanding of autism.
Currently, there is one orphan drug designated for autism: Fluoxetine, which is being evaluated for its potential benefits in this population. There are also 619 active clinical trials exploring various aspects of autism, including treatment options and interventions. You can find more information on these trials by visiting ClinicalTrials.gov and searching for autism-related studies.
Actionable guidance for navigating care for autism
To navigate autism effectively, consider consulting with a developmental pediatrician or a child psychologist who specializes in autism spectrum disorders. These specialists can provide tailored assessments and interventions. Additionally, you may explore resources such as the National Institute of Mental Health (NIMH) website at nimh.nih.gov for research updates and support. While no patient organizations are currently identified, participating in clinical trials may offer access to cutting-edge therapies and contribute to the understanding of autism.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation on autism is limited due to its multifactorial nature and the complexity of its clinical presentation. Because autism affects a diverse population and encompasses a wide range of symptoms and severity, systematic studies have been challenging. Additionally, the lack of identified genes complicates the understanding of its etiology, making comprehensive clinical characterization ongoing.
The clinical features of autism often present with neurological symptoms such as EEG abnormalities and seizures, occurring in 30-79% of cases. Additionally, many individuals exhibit increased serum serotonin levels, which can also be a notable characteristic. These features highlight the complexity of autism and the variability in its presentation among individuals.
To navigate autism effectively, consider consulting with a developmental pediatrician or a child psychologist who specializes in autism spectrum disorders. These specialists can provide tailored assessments and interventions. Additionally, you may explore resources such as the National Institute of Mental Health (NIMH) website at nimh.nih.gov for research updates and support. While no patient organizations are currently identified, participating in clinical trials may offer access to cutting-edge therapies and contribute to the understanding of autism.
Currently, there is one orphan drug designated for autism: Fluoxetine, which is being evaluated for its potential benefits in this population. There are also 619 active clinical trials exploring various aspects of autism, including treatment options and interventions. You can find more information on these trials by visiting ClinicalTrials.gov and searching for autism-related studies.
Actionable guidance for navigating care for autism
To navigate autism effectively, consider consulting with a developmental pediatrician or a child psychologist who specializes in autism spectrum disorders. These specialists can provide tailored assessments and interventions. Additionally, you may explore resources such as the National Institute of Mental Health (NIMH) website at nimh.nih.gov for research updates and support. While no patient organizations are currently identified, participating in clinical trials may offer access to cutting-edge therapies and contribute to the understanding of autism.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation on autism is limited due to its multifactorial nature and the complexity of its clinical presentation. Because autism affects a diverse population and encompasses a wide range of symptoms and severity, systematic studies have been challenging. Additionally, the lack of identified genes complicates the understanding of its etiology, making comprehensive clinical characterization ongoing.
The clinical features of autism often present with neurological symptoms such as EEG abnormalities and seizures, occurring in 30-79% of cases. Additionally, many individuals exhibit increased serum serotonin levels, which can also be a notable characteristic. These features highlight the complexity of autism and the variability in its presentation among individuals.
To navigate autism effectively, consider consulting with a developmental pediatrician or a child psychologist who specializes in autism spectrum disorders. These specialists can provide tailored assessments and interventions. Additionally, you may explore resources such as the National Institute of Mental Health (NIMH) website at nimh.nih.gov for research updates and support. While no patient organizations are currently identified, participating in clinical trials may offer access to cutting-edge therapies and contribute to the understanding of autism.
Currently, there is one orphan drug designated for autism: Fluoxetine, which is being evaluated for its potential benefits in this population. There are also 619 active clinical trials exploring various aspects of autism, including treatment options and interventions. You can find more information on these trials by visiting ClinicalTrials.gov and searching for autism-related studies.
Actionable guidance for navigating care for autism
To navigate autism effectively, consider consulting with a developmental pediatrician or a child psychologist who specializes in autism spectrum disorders. These specialists can provide tailored assessments and interventions. Additionally, you may explore resources such as the National Institute of Mental Health (NIMH) website at nimh.nih.gov for research updates and support. While no patient organizations are currently identified, participating in clinical trials may offer access to cutting-edge therapies and contribute to the understanding of autism.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 9 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning autism
Updated Jan 27, 2026
The CDC is seeking public comments on a proposed information collection project aimed at promoting resources for autistic teens and young adults. This initiative aligns with the Paperwork Reduction Act of 1995 and aims to enhance the utility of government information.
A recent systematic review confirms that the use of paracetamol during pregnancy does not increase the risk of autism, ADHD, or intellectual disability. The EMA maintains that paracetamol is a crucial option for managing pain or fever in pregnant women based on extensive scientific data.
The CDC held a media briefing discussing autism spectrum disorder, focusing on awareness and public health initiatives. This event aims to enhance understanding and support for individuals affected by autism.
CDC will hold a telebriefing to discuss the prevalence of autism spectrum disorders based on the latest MMWR surveillance summary. This event is primarily for media and does not present new data or policy changes.